D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PUCK
1801
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
| $5.94M | 0.01% |
590,193
+244,604
| +71% | +$2.43M |
|
1802
CALL
Canadian National Railway
CNI
$78.1B
| $5.94M | 0.01% |
50,000
| – | – |
|
1803
PUT
EPAM Systems
EPAM
$4.91B
| $5.93M | 0.01% |
18,100
-9,900
| -35% | -$3.37M |
|
1804
FS KKR Capital
FSK
$3.03B
| $5.93M | 0.01% |
338,925
+316,060
| +1,382% | +$5.88M |
|
1805
Brighthouse Financial
BHF
$3.62B
| $5.91M | 0.01% |
115,254
+47,547
| +70% | +$2.49M |
|
1806
CALL
Take-Two Interactive
TTWO
$45.3B
| $5.9M | 0.01% |
56,700
+15,100
| +36% | +$1.64M |
|
1807
Envoy Medical
COCH
$52.9M
| $5.9M | 0.01% |
584,288
+103,788
| +22% | +$1.03M |
|
1808
Dell
DELL
$276B
| $5.9M | 0.01% |
146,624
+96,905
| +195% | +$3.83M |
|
1809
PUT
Clorox
CLX
$11.8B
| $5.89M | 0.01% |
42,000
-1,500
| -3% | -$213K |
|
|
LPRO
1810
Open Lending Corp
LPRO
$373M
| $5.89M | 0.01% |
872,246
+321,222
| +58% | +$2.26M |
|
1811
Factset
FDS
$9.44B
| $5.88M | 0.01% |
14,660
-3,233
| -18% | -$1.38M |
|
|
SGII
1812
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
| $5.88M | 0.01% |
576,378
| – | – |
|
1813
Lexicon Pharmaceuticals
LXRX
$991M
| $5.88M | 0.01% |
3,077,973
+33,996
| +1% | +$72.3K |
|
1814
CALL
Capri Holdings
CPRI
$1.83B
| $5.86M | 0.01% |
102,300
+58,000
| +131% | +$2.93M |
|
1815
PUT
Lightspeed Commerce
LSPD
$1.35B
| $5.86M | 0.01% |
410,000
-103,000
| -20% | -$1.68M |
|
1816
PUT
AGNC Investment
AGNC
$12.4B
| $5.85M | 0.01% |
565,100
+436,800
| +340% | +$3.99M |
|
1817
CALL
RingCentral
RNG
$4.49B
| $5.84M | 0.01% |
165,000
-30,300
| -16% | -$1.08M |
|
1818
CALL
Celanese
CE
$4.87B
| $5.84M | 0.01% |
57,100
| – | – |
|
1819
AvalonBay Communities
AVB
$27B
| $5.82M | 0.01% |
36,059
-5,587
| -13% | -$951K |
|
1820
PUT
Paychex
PAYX
$41.1B
| $5.81M | 0.01% |
50,300
-4,800
| -9% | -$562K |
|
1821
CALL
H&R Block
HRB
$5.37B
| $5.8M | 0.01% |
158,800
+102,900
| +184% | +$4.18M |
|
|
FRON
1822
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
| $5.79M | 0.01% |
574,267
+300
| +0.1% | +$3K |
|
1823
PUT
Regal Rexnord
RRX
$14B
| $5.78M | 0.01% |
48,200
-10,000
| -17% | -$1.31M |
|
1824
CALL
Regeneron Pharmaceuticals
REGN
$70.2B
| $5.77M | 0.01% |
8,000
| – | – |
|
|
NVMI
1825
Nova
NVMI
$13.6B
| $5.77M | 0.01% |
70,663
+18,157
| +35% | +$1.48M |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.